- Home
- TECH vs CFLT Comparison
TECH vs CFLT Comparison
Compare TECH & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CFLT
- Stock Information
- Founded
- TECH 1976
- CFLT 2014
- Country
- TECH United States
- CFLT United States
- Employees
- TECH N/A
- CFLT N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CFLT EDP Services
- Sector
- TECH Health Care
- CFLT Technology
- Exchange
- TECH Nasdaq
- CFLT Nasdaq
- Market Cap
- TECH 12.0B
- CFLT 10.3B
- IPO Year
- TECH 1989
- CFLT 2021
- Fundamental
- Price
- TECH $78.75
- CFLT $27.51
- Analyst Decision
- TECH Buy
- CFLT Buy
- Analyst Count
- TECH 8
- CFLT 27
- Target Price
- TECH $82.00
- CFLT $32.41
- AVG Volume (30 Days)
- TECH 799.7K
- CFLT 3.2M
- Earning Date
- TECH 02-05-2025
- CFLT 02-11-2025
- Dividend Yield
- TECH 0.41%
- CFLT N/A
- EPS Growth
- TECH N/A
- CFLT N/A
- EPS
- TECH 0.95
- CFLT N/A
- Revenue
- TECH $1,171,583,000.00
- CFLT $915,606,000.00
- Revenue This Year
- TECH $7.67
- CFLT $25.89
- Revenue Next Year
- TECH $9.29
- CFLT $21.35
- P/E Ratio
- TECH $83.01
- CFLT N/A
- Revenue Growth
- TECH 2.41
- CFLT 25.01
- 52 Week Low
- TECH $61.16
- CFLT $17.79
- 52 Week High
- TECH $85.57
- CFLT $35.07
- Technical
- Relative Strength Index (RSI)
- TECH 63.59
- CFLT 43.92
- Support Level
- TECH $73.67
- CFLT $26.04
- Resistance Level
- TECH $78.44
- CFLT $28.67
- Average True Range (ATR)
- TECH 2.50
- CFLT 0.91
- MACD
- TECH 0.45
- CFLT -0.20
- Stochastic Oscillator
- TECH 99.13
- CFLT 34.67
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CFLT Confluent Inc.
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.